17 KiB
17 KiB
| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | 2003 SCHWARTZ EGFR | 2003 Schwartz eGFR | 191 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 4 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||||
| 5 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.0 | 0 - 6.2 | umol/L | ||||||||||
| 6 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Alkaline Phosphatase | 282 | 82 - 331 | U/L | ||||||||||
| 7 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | ALT (SGPT) | 16 | 6 - 43 | U/L | ||||||||||
| 8 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | AST (SGOT) | 26 | 10 - 40 | U/L | ||||||||||
| 9 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | GGT | 15 | 0 - 51 | U/L | ||||||||||
| 10 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | LDH | 214 | 105 - 235 | U/L | ||||||||||
| 11 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Urea Nitrogen | 4.0 | 1.4 - 8.6 | mmol/L | ||||||||||
| 12 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 51 | 23 - 83 | umol/L | ||||||||||
| 13 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Serum Glucose | 4.3 | 3.9 - 5.6 | mmol/L | ||||||||||
| 14 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Serum Uric Acid | 336 | 184 - 416 | umol/L | ||||||||||
| 15 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Calcium (EDTA) | 2.47 | 2.1 - 2.57 | mmol/L | ||||||||||
| 16 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Phosphorus | 1.58 | 0.71 - 1.65 | mmol/L | ||||||||||
| 17 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Total Protein | 85 | H | 61 - 84 | g/L | |||||||||
| 18 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Albumin-BCG | 44 | 29 - 47 | g/L | ||||||||||
| 19 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Creatine Kinase | 65 | 18 - 363 | U/L | ||||||||||
| 20 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Serum Sodium | 136 | 132 - 147 | mmol/L | ||||||||||
| 21 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Serum Potassium | 4.7 | 3.5 - 5.2 | mmol/L | ||||||||||
| 22 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Serum Bicarbonate | 23.4 | 19.3 - 29.3 | mmol/L | ||||||||||
| 23 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||||
| 24 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CHEMISTRY PANEL | Magnesium | 0.81 | 0.7 - 0.9 | mmol/L | ||||||||||
| 25 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | CRP COPY | C Reactive Protein COPY | 1.9 | 0.4 - 2 | mg/L | ||||||||||
| 26 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | FECAL CALPROTECTIN COPY | Fecal Calprotectin COPY | 3749.9 | H | Normal: <80ug/g$Borderline: 80-160$ug/g. Elevated:>160$ug/g | ||||||||||
| 27 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | FECAL COLLECTION D/T | Stool Collection Date | Y | 17-May-2026 | |||||||||||
| 28 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | FECAL COLLECTION D/T | Stool Collection Time | Y | 18:00 | |||||||||||
| 29 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 114 | L | 127 - 181 | g/L | |||||||||
| 30 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.37 | L | 0.39 - 0.54 | ||||||||||
| 31 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.2 | L | 4.5 - 6.4 | TI/L | |||||||||
| 32 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 27 | 26 - 34 | pg | ||||||||||
| 33 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 34 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 87 | 79 - 96 | fL | ||||||||||
| 35 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 9.73 | 4.35 - 13.15 | GI/L | ||||||||||
| 36 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 5.06 | 1.65 - 8.15 | GI/L | ||||||||||
| 37 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 3.42 | 0.95 - 5.25 | GI/L | ||||||||||
| 38 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.83 | 0.4 - 1.3 | GI/L | ||||||||||
| 39 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.34 | H | 0 - 0.3 | GI/L | |||||||||
| 40 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.10 | 0 - 0.2 | GI/L | ||||||||||
| 41 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 52.0 | 40.5 - 75 | % | ||||||||||
| 42 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 35.1 | 15.4 - 48.5 | % | ||||||||||
| 43 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 8.5 | H | 4 - 8 | % | |||||||||
| 44 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.5 | H | 0 - 2.8 | % | |||||||||
| 45 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 1 | % | ||||||||||
| 46 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 607 | H | 140 - 400 | GI/L | |||||||||
| 47 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 48 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | LIPID PANEL | Direct HDL-C 4th Generation | 1.27 | 1.03 - 1.53 | mmol/L | ||||||||||
| 49 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | LIPID PANEL | Triglycerides (GPO) | 1.17 | 0.42 - 1.67 | mmol/L | ||||||||||
| 50 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | LIPID PANEL | Cholesterol (High Performance) | 3.50 | 2.95 - 5.12 | mmol/L | ||||||||||
| 51 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | LIPID PANEL | LDL Chol Friedewald 4th | 1.69 | 0 - 3.34 | mmol/L | ||||||||||
| 52 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 53 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 18-May-2026 | |||||||||||
| 54 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 09:28 | |||||||||||
| 55 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 18-May-2026 | |||||||||||
| 56 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 10:52 | |||||||||||
| 57 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 18-May-2026 | |||||||||||
| 58 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 09:28 | |||||||||||
| 59 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 17-May-2026 | |||||||||||
| 60 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 18:00 | |||||||||||
| 61 | CZ100201001 | Male | Induction Week 0 | May 18, 2026 9:28 AM | 6227993966 | SUBJECT HEIGHT (CM) | Height (cm) | Y | 157 | cm | ||||||||||
| 62 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | ANATOMICAL SITE | Anatomical Site | Y | 20-25 | |||||||||||
| 63 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 64 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 65 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 15-Apr-2026 | |||||||||||
| 66 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 13:00 | |||||||||||
| 67 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 68 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 69 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 70 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 10:00 | ||||||||||||
| 71 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 17-Apr-2026 | ||||||||||||
| 72 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 73 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 74 | CZ100201001 | Male | Biopsy | Apr 15, 2026 12:00 AM | 6227993984 | ULCERATED AREA | Is biopsy site ulcerated? | No | ||||||||||||
| 75 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | 2003 SCHWARTZ EGFR | 2003 Schwartz eGFR | 211 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 76 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||||
| 77 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.2 | 0 - 6.2 | umol/L | ||||||||||
| 78 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Alkaline Phosphatase | 322 | 82 - 331 | U/L | ||||||||||
| 79 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | ALT (SGPT) | 20 | 6 - 43 | U/L | ||||||||||
| 80 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | AST (SGOT) | 29 | 10 - 40 | U/L | ||||||||||
| 81 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | GGT | 17 | 0 - 51 | U/L | ||||||||||
| 82 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | LDH | 221 | 105 - 235 | U/L | ||||||||||
| 83 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Urea Nitrogen | 3.6 | 1.4 - 8.6 | mmol/L | ||||||||||
| 84 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 46 | 23 - 83 | umol/L | ||||||||||
| 85 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Serum Glucose | 4.1 | 3.9 - 5.6 | mmol/L | ||||||||||
| 86 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Serum Uric Acid | 326 | 184 - 416 | umol/L | ||||||||||
| 87 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Calcium (EDTA) | 2.57 | 2.1 - 2.57 | mmol/L | ||||||||||
| 88 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Phosphorus | 1.72 | H | 0.71 - 1.65 | mmol/L | |||||||||
| 89 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Total Protein | 87 | H | 61 - 84 | g/L | |||||||||
| 90 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Albumin-BCG | 45 | 29 - 47 | g/L | ||||||||||
| 91 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Creatine Kinase | 94 | 18 - 363 | U/L | ||||||||||
| 92 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Serum Sodium | 136 | 132 - 147 | mmol/L | ||||||||||
| 93 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Serum Potassium | 4.9 | 3.5 - 5.2 | mmol/L | ||||||||||
| 94 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Serum Bicarbonate | 20.7 | 19.3 - 29.3 | mmol/L | ||||||||||
| 95 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||||
| 96 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | CHEMISTRY PANEL | Magnesium | 0.77 | 0.7 - 0.9 | mmol/L | ||||||||||
| 97 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 98 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 118 | L | Result verified by repeat analysis | 127 - 181 | g/L | ||||||||
| 99 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.37 | L | 0.39 - 0.54 | ||||||||||
| 100 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.2 | L | Result verified by repeat analysis | 4.5 - 6.4 | TI/L | ||||||||
| 101 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 28 | Result verified by repeat analysis | 26 - 34 | pg | |||||||||
| 102 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 103 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 87 | 79 - 96 | fL | ||||||||||
| 104 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 10.04 | Result verified by repeat analysis | 4.35 - 13.15 | GI/L | |||||||||
| 105 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 5.19 | Result verified by repeat analysis | 1.65 - 8.15 | GI/L | |||||||||
| 106 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 3.73 | 0.95 - 5.25 | GI/L | ||||||||||
| 107 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.77 | Result verified by repeat analysis | 0.4 - 1.3 | GI/L | |||||||||
| 108 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.29 | Result verified by repeat analysis | 0 - 0.3 | GI/L | |||||||||
| 109 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | Result verified by repeat analysis | 0 - 0.2 | GI/L | |||||||||
| 110 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 51.7 | Result verified by repeat analysis | 40.5 - 75 | % | |||||||||
| 111 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 37.2 | Result verified by repeat analysis | 15.4 - 48.5 | % | |||||||||
| 112 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.6 | Result verified by repeat analysis | 4 - 8 | % | |||||||||
| 113 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.9 | H | Result verified by repeat analysis | 0 - 2.8 | % | ||||||||
| 114 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | Result verified by repeat analysis | 0 - 1 | % | |||||||||
| 115 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 490 | H | Result verified by repeat analysis | 140 - 400 | GI/L | ||||||||
| 116 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 117 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Reactive | Ref Rng :$Non Reactive | |||||||||||
| 118 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 119 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 120 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 121 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 122 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 123 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 124 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 125 | CZ100201001 | Male | Screening | Apr 13, 2026 12:20 PM | 6227993962 | SUBJECT HEIGHT (CM) | Height (cm) | Y | 157 | cm | ||||||||||
| 126 | CZ100201001 | Male | Stool Pathogens | Apr 13, 2026 6:00 AM | 6227993971 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 127 | CZ100201001 | Male | Stool Pathogens | Apr 13, 2026 6:00 AM | 6227993971 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative |